Steve Ubl, CEO of the Pharmaceutical Research and Manufacturers of America, said he remains "hopeful" the Trump administration will reconsider its proposal to lower drug prices, according to The Hill.
Pharmacy
Allergan and the St. Regis Mohawk Tribe will continue their legal battle in defense of a patent agreement struck in 2017, appealing a lower court decision to the U.S. Supreme Court, according to STAT.
Purdue Pharma formed relationships with two Boston-based organizations — Massachusetts General Hospital and Tufts University School of Medicine — to boost prescription rates and generate goodwill toward opioids as painkillers, according to a court filing released Jan. 15.
Pharmedium, AmerisourceBergen's troubled compounding unit, will lay off 225 workers at its Memphis, Tenn., facility by March 12, according to the Commercial Appeal.
Pfizer is ending five preclinical programs in its biosimilar research and development unit, which will result in 150 employees losing their jobs, according to a BioSpace news report.
CVS has already sent shockwaves through the healthcare industry with its first-of-a-kind merger with health insurer Aetna — but its path to transforming healthcare won't stop there, CVS CEO Larry Merlo said at a National Press Club luncheon Jan. 14,…
Hospital drug spending jumped by 18.5 percent between 2015 and 2017, a rate that caused one in four hospitals to cut staff to ease budget pressures, a new study found.
Patrick Soon-Shiong, MD, a biotechnology entrepreneur and CEO of NantHealth, saw his net worth jump after pharmaceutical manufacturer Bristol-Myers Squibb announced a deal to purchase Celgene for roughly $74 million earlier this month, according to Forbes.
Jake Thompson, PharmD, serves as CEO of Elevate340B, a company dedicated to helping hospitals and clinics optimize their pharmaceutical purchasing.
Joe Vargas is the regional director of pharmacy operations for CompleteRx, a pharmacy management, consulting and operations improvement provider.